82 related articles for article (PubMed ID: 33418682)
21. Tissue-engineered nanoclay-based 3D in vitro breast cancer model for studying breast cancer metastasis to bone.
Kar S; Molla MS; Katti DR; Katti KS
J Tissue Eng Regen Med; 2019 Feb; 13(2):119-130. PubMed ID: 30466156
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
23. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
[TBL] [Abstract][Full Text] [Related]
24. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
[TBL] [Abstract][Full Text] [Related]
25. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
26. Model-Based Integration Analysis Revealed Presence of Novel Prognostic miRNA Targets and Important Cancer Driver Genes in Triple-Negative Breast Cancers.
Zaka M; Sutton CW; Peng Y; Konur S
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32182819
[No Abstract] [Full Text] [Related]
27. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
28. Electrospinning PCL Scaffolds Manufacture for Three-Dimensional Breast Cancer Cell Culture.
Rabionet M; Yeste M; Puig T; Ciurana J
Polymers (Basel); 2017 Aug; 9(8):. PubMed ID: 30971005
[TBL] [Abstract][Full Text] [Related]
29. Luteolin Inhibits Breast Cancer Development and Progression In Vitro and In Vivo by Suppressing Notch Signaling and Regulating MiRNAs.
Sun DW; Zhang HD; Mao L; Mao CF; Chen W; Cui M; Ma R; Cao HX; Jing CW; Wang Z; Wu JZ; Tang JH
Cell Physiol Biochem; 2015; 37(5):1693-711. PubMed ID: 26545287
[TBL] [Abstract][Full Text] [Related]
30. Identification of Breast Cancer Subtype Specific MicroRNAs Using Survival Analysis to Find Their Role in Transcriptomic Regulation.
Denkiewicz M; Saha I; Rakshit S; Sarkar JP; Plewczynski D
Front Genet; 2019; 10():1047. PubMed ID: 31798622
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
32. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.
Braicu C; Buiga R; Cojocneanu R; Buse M; Raduly L; Pop LA; Chira S; Budisan L; Jurj A; Ciocan C; Magdo L; Irimie A; Dobrota F; Petrut B; Berindan-Neagoe I
J Exp Clin Cancer Res; 2019 Oct; 38(1):433. PubMed ID: 31665050
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
34. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
Hanieh H
Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
[TBL] [Abstract][Full Text] [Related]
35. Integrated analysis of the miRNA-mRNA next-generation sequencing data for finding their associations in different cancer types.
Bhowmick SS; Bhattacharjee D; Rato L
Comput Biol Chem; 2020 Feb; 84():107152. PubMed ID: 31785969
[TBL] [Abstract][Full Text] [Related]
36. The Volume of Three-Dimensional Cultures of Cancer Cells InVitro Influences Transcriptional Profile Differences and Similarities with Monolayer Cultures and Xenografted Tumors.
Boghaert ER; Lu X; Hessler PE; McGonigal TP; Oleksijew A; Mitten MJ; Foster-Duke K; Hickson JA; Santo VE; Brito C; Uziel T; Vaidya KS
Neoplasia; 2017 Sep; 19(9):695-706. PubMed ID: 28787674
[TBL] [Abstract][Full Text] [Related]
37. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
McAnena P; Tanriverdi K; Curran C; Gilligan K; Freedman JE; Brown JAL; Kerin MJ
BMC Cancer; 2019 May; 19(1):436. PubMed ID: 31077182
[TBL] [Abstract][Full Text] [Related]
38. Inferring coregulation of transcription factors and microRNAs in breast cancer.
Wu JH; Sun YJ; Hsieh PH; Shieh GS
Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
[TBL] [Abstract][Full Text] [Related]
39. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
40. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
Wilk G; Braun R
Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
